These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16982882)

  • 21. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
    Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
    Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
    Cannons JL; Choi Y; Watts TH
    J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
    Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX
    J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
    May KF; Chen L; Zheng P; Liu Y
    Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
    Hernandez-Chacon JA; Li Y; Wu RC; Bernatchez C; Wang Y; Weber JS; Hwu P; Radvanyi LG
    J Immunother; 2011 Apr; 34(3):236-50. PubMed ID: 21389874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
    Bertram EM; Lau P; Watts TH
    J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
    Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
    J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.
    Myers L; Takahashi C; Mittler RS; Rossi RJ; Vella AT
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5348-53. PubMed ID: 12695569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune regulation and control of regulatory T cells by OX40 and 4-1BB.
    So T; Lee SW; Croft M
    Cytokine Growth Factor Rev; 2008; 19(3-4):253-62. PubMed ID: 18508403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling.
    Sun Y; Blink SE; Chen JH; Fu YX
    J Immunol; 2005 Jul; 175(2):884-90. PubMed ID: 16002686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costimulation of CD8 T cell responses by OX40.
    Bansal-Pakala P; Halteman BS; Cheng MH; Croft M
    J Immunol; 2004 Apr; 172(8):4821-5. PubMed ID: 15067059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen.
    Song A; Tang X; Harms KM; Croft M
    J Immunol; 2005 Sep; 175(6):3534-41. PubMed ID: 16148096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
    Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
    J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
    Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
    World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB.
    Arch RH; Thompson CB
    Mol Cell Biol; 1998 Jan; 18(1):558-65. PubMed ID: 9418902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice.
    Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgström P; Lustgarten J
    Int J Cancer; 2005 Oct; 116(6):934-43. PubMed ID: 15856473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
    Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
    J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.